In T-cell-transfer colitis model, the activation of TRPV1 tended to exacerbate the intestinal inflammation, while the colitis was less severe when the TRPV1 in T cell was genetically or pharmacologically inhibited. The gene discussed is TRPV1; the disease is inflammatory response.